Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin

BACKGROUND: Patients with type 2 diabetes mellitus (T2DM) are characterized by an elevated glycemic index and are at a higher risk for complications such as cardiovascular disease, nephropathy, retinopathy and peripheral neuropathy. Normalization of glycemic index can be achieved by dosing combinati...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Pharmacol Toxicol
Hlavní autoři: Dobbins, Robert, Hussey, Elizabeth K., O’Connor-Semmes, Robin, Andrews, Susan, Tao, Wenli, Wilkison, William O., Cheatham, Bentley, Sagar, Katare, Hanmant, Barkate
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8201735/
https://ncbi.nlm.nih.gov/pubmed/34120651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-021-00502-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky